TrialCNS drugs2018

Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial.

Jayashri Kulkarni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.